SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2017 Biotech Charity Contest -- Ignore unavailable to you. Want to Upgrade?


To: BulbaMan who wrote (117)1/6/2017 8:58:21 PM
From: A.J. Mullen  Respond to of 344
 
I had realized it had been a good week, but not how good. With four companies up more than ten percent, one up 20%, and none negative; I was sure I'd be in the top ten. Not only did I not place, neither did any of my picks. Good times or bad: stock-picking is hard!

Thanks, as ever, Bulba.

Ashley



To: BulbaMan who wrote (117)1/10/2017 2:57:32 PM
From: Steve Lokness4 Recommendations

Recommended By
IRWIN JAMES FRANKEL
rkrw
scaram(o)uche
Thehammer

  Read Replies (1) | Respond to of 344
 
$2,700 donations in a single day from 14 people yesterday to Catalyst Garden. That is not a total as there were donations before that and at least some today that are not a part of that total - but as a one day total that is pretty impressive. ..............Way to go guys!!!!!



To: BulbaMan who wrote (117)1/13/2017 6:48:34 PM
From: BulbaMan1 Recommendation

Recommended By
rkrw

  Read Replies (1) | Respond to of 344
 
1/13/2017 Contest update
PEOTUS Trump “murdered” biotechs at his Wednesday press conference but the corpse was mysteriously resurrected on Thursday. The next time Trump is a pill about pill prices should we call in the Texas Rangers?
youtube.com
Meanwhile, at Friday’s close, the Contest median was up 7.91% YTD (vs. up 6.48% YTD a week ago), the Nasdaq Biotech Index (NBI) was up 5.73% YTD (vs. up 5.69% YTD a week ago) and the smaller-cap S&P Biotechnology Select Industry Index (SPSIBI) was up 9.92% YTD (vs. up 7.11% YTD a week ago). The Nasdaq Composite Index (NCI) closed up 3.55% YTD (vs. up 2.56% YTD a week ago).
The ARIA buyout at a fat premium was the week’s big biotech news. So it’s no surprise our new Contest leader is 20% ARIA holder, JBOG’s portfolio, up 26.43% YTD. Helped by the week’s second largest gainer, GNVC, DANIEL’s portfolio, up 20.15% YTD, took second place. And another ARIA holder, TOMP’s portfolio, up 19.34% YTD, is in third place .
At Friday's close, 44 of the 48 Contest portfolios were still in the green, with 33 beating the NBI and 14 beating the SPSIBI.
The 195 Contest portfolio stock picks have an average YTD gain of 6.59% and a median YTD gain of 5.38%, with 145 of the 195 picks up for the year.
Below is the Top Ten list. Also below are the Top 5 & Bottom 5 Stocks for the week ranked by % Gained and % Lost YTD. (Prices not converted to US$ in these Tables.)
Portfolio adjustments: None.
(All corrections, especially adjustments for splits, greatly appreciated.)
Have a relaxing Martin Luther King Jr. weekend biotechies!
Peace & good health,
Bulba

			1/13/17	
Rank Name Profit/Loss
1 JBOG 26,428
2 DANIEL 20,153
3 TOMP 19,340
4 HRS 17,072
5 BIOMAV 16,387
6 OLIVIER 14,669
7 TUCK 14,410
8 SMALLB 14,072
9 GENE 13,949
10 BIOADD 13,846

Week's Top 5 Gainers
Symbol 1/6/17 1/13/17 Wk.%chg.
ARIA 13.74 23.69 72.42%
GNVC 3.66 6.14 67.76%
MGN.DE 1.46 2.08 42.47%
SRPT 30.08 37.83 25.76%
ARRY 8.94 10.87 21.59%

Week's Worst 5 Losers
Symbol 1/6/17 1/13/17 Wk.%chg.
AMAG 35.70 23.00 -35.57%
PTN 0.55 0.44 -19.80%
NSTG 22.75 18.94 -16.75%
HALO 13.380 11.390 -14.87%
APTO 1.32 1.14 -13.64%